chevron_leftBack
As of 17 June 2026, Sibannac, Inc. has a market cap of $2.02M USD, ranking #47234 globally and #5995 in the United States.
It ranks #4183 in the Healthcare sector, and #319 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$2.02MUSD
Revenue (TTM)
$434.00USD
Net Income (TTM)
-$526.74KUSD
PS Ratio
4654.1
PB Ratio
-46.0
Company Profile
Country (HQ)
Sector
Healthcare
CEO
David Mersky
open_in_new
Employees
1
Website
snncinc.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 6.6% | 24% | 204% | 14% | -7.5% | -45% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SNNC
Sibannac Inc
ISIN: US82572P1003
Shares Out.:
Shares Outstanding:
135.562M1
Shares Float:
42.136M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0148 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sibannac, Inc.
Sibannac, Inc. operates as a media and management services company. It serves businesses with online marketing, advertising, sales tracking, management consulting, and other informational services. The company also provides accounting, and expense and labor management systems to assist in compliance in the regulated industry environment. Sibannac, Inc. is based in Phoenix, Arizona.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: RVMD
|
$29.56B
1M%
|
-
|
|
LSE: INDV
|
$2.07B
103K%
1.54B GBP
|
-
|
|
OTCMKTS: NDOI
|
$1.8B
89K%
|
0.4
|
|
NASDAQ: DVAX
|
$1.76B
87K%
|
-
|
|
NASDAQ: AVBP
|
$1.33B
66K%
|
-
|
|
NYSE: BRBR
|
$1.03B
51K%
|
12.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.53B
2M%
108.92B ILS
|
24.2
|
|
SHE: 002001
|
$15.85B
785K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.26B
557K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.14B
551K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.1B
450K%
61.6B CNY
|
80.6
|
|
EPA: ABVX
|
$8.77B
434K%
7.57B EUR
|
-
|
chevron_leftBack